The PRECIOUS Study: Predicting Crohn's & Colitis Outcomes in the United States

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Inflammatory Bowel Disease
  • Age: Between 16 - 80 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Subjects with active UC or CD with typical symptoms in conjunction with at least one objective measure of disease activity: elevated CRP, calprotectin, endoscopic evidence.
    2. Subjects not currently receiving systemic therapy* with steroids, immunomodulators or biologics, and at least 7 days since the last steroid dose.
    3. Subjects due to be managed using a “step-up” or “accelerated step-up” approach (so will not receive biologics as first line therapy).
    4. Subjects who are aged 16 - 80 years old
    5. Subjects who are able to provide written informed consent

You may not be eligible for this study if the following are true:

    1. Subjects with fistulating peri-anal Crohn’s disease or active perianal sepsis
    2. Subjects who have obstructive symptoms and evidence of a fixed stricture on radiology or colonoscopy
    3. Subjects who are scheduled to start on “top-down” therapy or receive biologics as a first line therapy



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.